Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01551576|
Recruitment Status : Suspended (logistics)
First Posted : March 12, 2012
Last Update Posted : August 19, 2019
|Condition or disease|
The primary objective of this pilot study is to assess PAI-performance in a clinical setting to understand limitations of our current PAI instrumentation and to help improve the next-generation design.
To do preliminary evaluations of oxygen saturation in lesions based on PAI-measurements in order to distinguish malignant from benign prostatic tissue as a basis for future studies.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study|
|Study Start Date :||February 2014|
|Estimated Primary Completion Date :||December 2020|
|Estimated Study Completion Date :||June 2021|
- lesion signal intensity on Photoacoustic Imaging (PAI) in relation to different lesion characteristics and the surrounding tissues [ Time Frame: 36 months ]The types of measures can be divided into three groups: 1) Operator determined measures during or just after the examination; 2) Post processing measures determined during post processing of the captured data and images; 3) Measures related to standard imaging and histopathological examination.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01551576
|United States, California|
|Stanford University Cancer Institute|
|Stanford, California, United States, 94305|
|Principal Investigator:||Sanjiv S Gambhir, MD, PhD||Stanford University|
|Principal Investigator:||Martin Karl Schneider, PhD||Stanford University|